methscopolamine bromide 5 MG Oral Tablet
methscopolamine bromide
RxCUI: 403914
What the CMS Formulary Data Shows for methscopolamine bromide 5 MG Oral Tablet
Per the CMS 2026 Part D formulary file, methscopolamine bromide 5 MG Oral Tablet (RxNorm concept RXCUI 403914, generic name methscopolamine bromide) appears on 73 distinct formulary files spanning 2,051 Medicare Part D plan offerings - 40.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.1.
Real-world access to methscopolamine bromide 5 MG Oral Tablet depends on utilization management as much as tier placement: 9.6% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,596 Part D beneficiaries filled methscopolamine bromide 5 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $836,854 and an average per-beneficiary annual cost of $524.34. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry methscopolamine bromide 5 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 73
- Plans covering
- 2,051
- Coverage rate
- 40.5%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 9.6% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,596
- Total spending
- $836,854
- Avg per beneficiary
- $524.34
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering methscopolamine bromide 5 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is methscopolamine bromide 5 MG Oral Tablet covered by Medicare Part D?
Yes, methscopolamine bromide 5 MG Oral Tablet is covered by 2,051 Medicare Part D plans (40.5% of all Part D formularies).
What tier is methscopolamine bromide 5 MG Oral Tablet on Medicare Part D plans?
methscopolamine bromide 5 MG Oral Tablet averages Tier 3.1 across Part D plans, ranging from Tier 1 to Tier 4.
Does methscopolamine bromide 5 MG Oral Tablet require prior authorization?
9.6% of Part D formularies require prior authorization for methscopolamine bromide 5 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on methscopolamine bromide 5 MG Oral Tablet?
In 2023, total Medicare Part D spending on methscopolamine bromide 5 MG Oral Tablet was $836,854, covering 1,596 beneficiaries. The average spend per beneficiary was $524.34.
Read our methodology - how this data is sourced, computed, and verified.